{"id":"https://openalex.org/W3005503000","doi":"https://doi.org/10.1200/jco.2020.38.4_suppl.710","title":"Efficacy of SBP-101, in combination with gemcitabine and nab-paclitaxel, in first-line treatment of metastatic pancreatic ductal adenocarcinoma.","display_name":"Efficacy of SBP-101, in combination with gemcitabine and nab-paclitaxel, in first-line treatment of metastatic pancreatic ductal adenocarcinoma.","publication_year":2020,"publication_date":"2020-02-01","ids":{"openalex":"https://openalex.org/W3005503000","doi":"https://doi.org/10.1200/jco.2020.38.4_suppl.710","mag":"3005503000"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.4_suppl.710","doi":"https://doi.org/10.1200/jco.2020.38.4_suppl.710","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.4_suppl.710","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052972588","display_name":"Dusan Kotasek","orcid":"https://orcid.org/0000-0002-2170-3560","observed_orcids":["https://orcid.org/0000-0002-2170-3560"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Dusan Kotasek","raw_affiliation_strings":["University of Adelaide, Adelaide, SA, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Adelaide, Adelaide, SA, Australia;","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070415176","display_name":"Adnan M. Nagrial","orcid":"https://orcid.org/0000-0003-0275-2479","observed_orcids":["https://orcid.org/0000-0003-0275-2479"]},"institutions":[{"id":"https://openalex.org/I2802314053","display_name":"Blacktown & Mount Druitt Hospital","ror":"https://ror.org/017bddy38","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2802314053","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Adnan Nagrial","raw_affiliation_strings":["Blacktown Hospital Cancer and Haematology Centre, Blacktown, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blacktown Hospital Cancer and Haematology Centre, Blacktown, NSW, Australia;","institution_ids":["https://openalex.org/I2802314053"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sumit Lumba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sumit Lumba","raw_affiliation_strings":["John Flynn Private Hospital Cancer and Haematology Centre, Tugun, QLD, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Flynn Private Hospital Cancer and Haematology Centre, Tugun, QLD, Australia;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080423970","display_name":"Niall Christopher Tebbutt","orcid":"https://orcid.org/0000-0003-2613-5168","observed_orcids":["https://orcid.org/0000-0003-2613-5168"]},"institutions":[{"id":"https://openalex.org/I4210157122","display_name":"Heidelberg Repatriation Hospital","ror":"https://ror.org/04dhg0348","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210157122","https://openalex.org/I4210163497"]},{"id":"https://openalex.org/I4210158799","display_name":"Olivia Newton-John Cancer Wellness & Research Centre","ror":"https://ror.org/04t908e09","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210158799"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Niall C. Tebbutt","raw_affiliation_strings":["Olivia Newton-John Cancer and Wellness Centre, \u00c3\u0192\u00c2,\u00c3,\u00c2 Heidelberg Repatriation Hospital, Heidelberg, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Olivia Newton-John Cancer and Wellness Centre, \u00c3\u0192\u00c2,\u00c3,\u00c2 Heidelberg Repatriation Hospital, Heidelberg, Australia;","institution_ids":["https://openalex.org/I4210157122","https://openalex.org/I4210158799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020154592","display_name":"Thomas J. George","orcid":"https://orcid.org/0000-0002-6249-9180","observed_orcids":["https://orcid.org/0000-0002-6249-9180"]},"institutions":[{"id":"https://openalex.org/I4390039331","display_name":"UF Health Cancer Center","ror":"https://ror.org/044vhe029","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144","https://openalex.org/I4390039331"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. George","raw_affiliation_strings":["University of Florida Health Cancer Center, Gainesville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Florida Health Cancer Center, Gainesville, FL;","institution_ids":["https://openalex.org/I4390039331"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059411835","display_name":"Sheri Lynn Smith","orcid":"https://orcid.org/0009-0005-6586-5763","observed_orcids":["https://orcid.org/0009-0005-6586-5763"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sheri Lynn Smith","raw_affiliation_strings":["Courante Oncology, Excelsior, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Courante Oncology, Excelsior, MN;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103173678","display_name":"Suzanne Gagnon","orcid":"https://orcid.org/0009-0007-3607-5425","observed_orcids":["https://orcid.org/0009-0007-3607-5425"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suzanne Gagnon","raw_affiliation_strings":["Sun BioPharma Inc, Jamestown, RI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sun BioPharma Inc, Jamestown, RI;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael T. Cullen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael T. Cullen","raw_affiliation_strings":["Sun BioPharma, Inc., Waconia, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sun BioPharma, Inc., Waconia, MN;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009809225","display_name":"Michael J. Walker","orcid":"https://orcid.org/0000-0003-1347-7636","observed_orcids":["https://orcid.org/0000-0003-1347-7636"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Walker","raw_affiliation_strings":["Sun BioPharma, Inc., Waconia, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sun BioPharma, Inc., Waconia, MN;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"4_suppl","first_page":"710","last_page":"710"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11924","display_name":"Polyamine Metabolism and Applications","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-pancreatic-ductal-adenocarcinoma","display_name":"metastatic pancreatic ductal adenocarcinoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9319999814033508},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9919999837875366},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.7509999871253967},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7770000100135803},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6850000023841858},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8600000143051147},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8510000109672546},{"id":"https://openalex.org/keywords/ca19-9","display_name":"CA19-9","score":0.8740000128746033},{"id":"https://openalex.org/keywords/objective-response","display_name":"objective response","score":0.4970000088214874},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9390000104904175},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9169999957084656},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.6290000081062317},{"id":"https://openalex.org/keywords/elevated-liver-enzymes","display_name":"elevated liver enzymes","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9445289969444275},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8479384183883667},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.828669548034668},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5905594825744629},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5248168706893921},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.48207932710647583},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45622003078460693},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.42954012751579285},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4290933907032013},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.39318251609802246},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3889543414115906},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.345866322517395},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.32684317231178284},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2672876715660095},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18761581182479858}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.4_suppl.710","doi":"https://doi.org/10.1200/jco.2020.38.4_suppl.710","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.4_suppl.710","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4206275800","https://openalex.org/W3167733335","https://openalex.org/W2889882862","https://openalex.org/W3005302843","https://openalex.org/W2514534355","https://openalex.org/W2011073871","https://openalex.org/W3098634978","https://openalex.org/W2090449643","https://openalex.org/W2560318616","https://openalex.org/W3029991274"],"abstract_inverted_index":{"710":[0],"Background:":[1],"SBP-101,":[2],"a":[3,40,79],"polyamine":[4],"metabolic":[5],"inhibitor,":[6],"inhibited":[7],"growth":[8],"in":[9,29,62,70,167,188,225,237,257,269,323],"6":[10,180],"human":[11,25],"pancreatic":[12],"ductal":[13],"adenocarcinoma":[14],"(PDA)":[15],"cell":[16],"lines":[17],"and":[18,58,67,106,117,123,129,157,176,191,206,253,260,287,294,313],"3":[19,168],"murine":[20],"xenograft":[21],"tumor":[22],"models":[23],"of":[24,43,60,87,99,119,138,182,215,244,271,316,321],"PDA.":[26,76,328],"SBP-101":[27,61,88,200,305,322],"monotherapy":[28],"heavily":[30],"pre-treated":[31],"PDA":[32],"patients":[33,71,163,281],"(>":[34],"2":[35,190,227,259],"prior":[36],"regimens,":[37],"N=4)":[38,175],"showed":[39],"median":[41],"survival":[42,155,159],"5.9":[44],"months":[45],"at":[46,91,246],"the":[47,54,242],"optimal":[48],"dose":[49,82],"level.":[50],"Purpose:":[51],"To":[52],"assess":[53],"safety,":[55],"tolerability,":[56],"PK,":[57],"efficacy":[59,317],"combination":[63,324],"with":[64,72,279,311],"gemcitabine":[65],"(G)":[66],"nab-paclitaxel":[68],"(A)":[69],"previously":[73],"untreated":[74],"metastatic":[75],"Methods:":[77],"In":[78,262],"modified":[80],"3+3":[81],"escalation":[83],"scheme,":[84],"subcutaneous":[85],"injections":[86],"were":[89,110,125,240,255],"dosed":[90],"0.2,":[92],"0.4":[93],"or":[94,220],"0.6":[95],"mg/kg":[96],"days":[97],"1-5":[98],"each":[100,120],"28-day":[101],"cycle.":[102,121],"G":[103,312],"(1000":[104],"mg/m2)":[105,109],"A":[107],"(125":[108],"administered":[111,310],"intravenously":[112],"on":[113,135],"Days":[114],"1,":[115],"8,":[116],"15":[118],"Safety":[122],"tolerability":[124],"evaluated":[126,134],"by":[127,144,151],"clinical":[128],"laboratory":[130],"assessments.":[131],"PK":[132,235],"was":[133,142],"day":[136],"1":[137,239,288],"cycle":[139],"1.":[140],"Efficacy":[141],"assessed":[143,150],"CA19-9":[145,265],"levels,":[146],"objective":[147],"response":[148],"as":[149],"RECIST":[152],"criteria,":[153],"progression-free":[154],"(PFS)":[156],"overall":[158],"(OS).":[160],"Results:":[161],"Fifteen":[162],"have":[164,296],"been":[165,299],"enrolled":[166],"cohorts":[169,189,258],"(1:":[170],"N=4,":[171],"2:":[172],"N=7,":[173],"3:":[174],"received":[177],"up":[178],"to":[179,199],"cycles":[181],"treatment":[183,326],"(7":[184],"subjects":[185,274],"are":[186,201],"ongoing":[187],"3).":[192],"The":[193],"most":[194,247],"common":[195],"adverse":[196],"events":[197],"related":[198],"fatigue":[202],"(N=4),":[203],"nausea":[204],"(N=2)":[205],"injection":[207],"site":[208],"pain":[209],"(N=2).":[210],"There":[211],"is":[212,306],"no":[213],"evidence":[214],"SBP-101-related":[216],"bone":[217],"marrow":[218],"suppression":[219],"peripheral":[221],"neuropathy.":[222],"One":[223],"patient":[224],"cohort":[226,238],"developed":[228],"grade":[229],"3-4":[230],"reversible":[231],"liver":[232],"enzyme":[233],"elevation.":[234],"parameters":[236],"below":[241],"limits":[243],"detection":[245],"time":[248],"points,":[249],"but":[250],"plasma":[251],"Cmax":[252],"AUC0-t":[254],"measurable":[256],"3.":[261],"those":[263],"cohorts,":[264],"levels":[266],"decreased":[267],"76-95%":[268],"7":[270],"8":[272],"evaluable":[273],"(1":[275],"additional":[276],"subject":[277],"TBD),":[278],"5":[280],"achieving":[282,289],"partial":[283],"responses":[284],"(4":[285],"ongoing)":[286],"stable":[290],"disease.":[291],"Median":[292],"PFS":[293],"OS":[295],"not":[297],"yet":[298],"reached.":[300],"Conclusions:":[301],"Preliminary":[302],"results":[303],"suggest":[304],"well":[307],"tolerated":[308],"when":[309],"A.":[314],"Signals":[315],"support":[318],"continued":[319],"development":[320],"first-line":[325],"for":[327],"Clinical":[329],"trial":[330],"information:":[331],"NCT03412799.":[332]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-02-14T00:00:00"}